SciELO - Scientific Electronic Library Online

 
vol.9 issue2Preliminary evaluation of different concentrations of bacterial suspensions used in the Whole Blood Bactericidal AssayIn vivo determination of adventitious agents in BHK-21 cells used in the production of biologicals author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Vaccimonitor

On-line version ISSN 1025-0298

Abstract

SANCHEZ SANCHEZ, Mercedes. Hepatitis B vaccine, a challenge to liver cancer. Vaccimonitor [online]. 2000, vol.9, n.2, pp. 19-22. ISSN 1025-0298.

In geographical regions where the hepatitis B virus (HBV) has high prevalence, liver cancer is the most common neoplasm. Infection control is becoming more complex because of the considerable amount of asymptomatic carriers that exist in the world now. Nevertheless, with the discovery and production of a vaccine against hepatitis B virus and its subsequent inclusion in the Expanded Program for Immunization, this situation could change, by reducing the number of new cases and carriers in the future. This should in consequence reduce the mortality by virus-caused liver carcinoma.

Keywords : Hepatitis B; epidemiology; vaccine; liver cancer.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License